AQR Capital Management - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$115,000
-12.2%
28,0690.0%0.00%
Q4 2017$131,000
-34.2%
28,0690.0%0.00%
Q3 2017$199,000
-80.6%
28,069
-61.2%
0.00%
-100.0%
Q4 2014$1,024,000
-10.9%
72,379
-13.4%
0.00%
-33.3%
Q3 2014$1,149,000
-20.5%
83,579
-11.1%
0.00%
-25.0%
Q2 2014$1,445,000
-12.5%
93,979
-3.0%
0.00%
-20.0%
Q1 2014$1,651,000
+4.0%
96,879
-21.0%
0.01%0.0%
Q4 2013$1,587,000
+28.2%
122,5790.0%0.01%
+25.0%
Q3 2013$1,238,000
+48.6%
122,579
+9.9%
0.00%
+33.3%
Q2 2013$833,000
+664.2%
111,579
+168.9%
0.00%
Q4 2012$109,00041,5000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders